New! GreenLight HPS EA (Extended Applications) Fiber for the treatment of Bladder Tumors and Urethral Strictures
According to the American Cancer Society, in 2007 more than 67,000 new cases of urinary bladder cancer were diagnosed in the United States. 1 Superficial bladder tumors, involving only the innner lining of the bladder, account for approsimately 70 to 80% of all bladder tumors. 2, 3
The new GreenLight HPS EA Fiber is designed to extend the proven GreenLight technology beyond the treatment of Bladder Tumors and Urethral Strictures.
GreenLight™ Laser Therapy Superior Results Come from Superior Technology
GreenLight Laser Therapy offers clinical outcomes equivalent to Transurethral Resection of the Prostate (TURP) for the treatment of BPH, with fewer complications. Over 100 clinical articles and 150 published abstracts have proven the safety and efficacy of GreenLight: no significant risk of TUR syndrome, fluid absorption or blood transfusion, and less than 1% of reported cases of erectile dysfunction.
For more information, download the GreenLight Laser Therapy Clinical Study Summary (pdf).
GreenLight Laser Therapy. It’s Proven. It’s in the Data.
- Over 100 Published Clinical Articles
- Over 135 Published Abstracts
- Over 7 Years Clinical History
- Over 300,000 Patients Treated World-Wide
Outcomes equivalent to TURP with fewer side effects and complications
- Rapid & dramatic flow rate improvement
- Widest patient selection: for mild to severe symptoms
- Additional studies support the use of GreenLight in large glands, anti-coagulant, and high risk patients
- Outpatient procedure
- Less risk than TURP ; no significant risk of TUR syndrome
- Less than 1% of patients reported erectile dysfunction
- 14 hour mean catheterization time
- Mild and short-lived irritative symptoms
- Sustained efficacy out to five years
- Quick return to normal activities